Biosimilars Market Size Worth USD 127.92 Billion by 2032 | CAGR 17.7% from 2024 to 2032
The Biosimilars Market was valued at USD 29.51 Billion in 2023 and is projected to reach USD 127.92 Billion by 2032, growing at a robust CAGR of 17.7% during the forecast period. Market growth is driven by rising demand for cost-effective biologic alternatives as patents for key biologics expire. The U.S. market, while previously limited by patent disputes and adoption barriers, is now gaining momentum with increasing FDA approvals and commercial launches.